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Stem cells are undifferentiated cells that can self-renew and
generate specialized (functional) cell types. The remarkable
abilityofstemcellstodifferentiatetowardsfunctionalcellsmakes
themsuitablemodalitiesincellulartherapy(whichmeanstreating
diseases with the body’s own cells). Potential targets for cellular
therapy include diabetes and liver failure. However, in order for
stem cells to be clinically useful, we must learn to identify them
and to regulate their differentiation. We will use the intestine
as a classical example of a stem cell compartment, and then
examine the evidence for the existence of adult stem cells in
two endodermally derived organs: pancreas and liver. We will
reviewthecharacteristicsoftheputativestemcellsinthesetissues
and the transcription factors controlling their differentiation
towards functional cell types.
Key words: cell differentiation, intestine, liver, pancreas, stem
cell, transdifferentiation.
INTRODUCTION
Stem cells are deﬁned as cells that can divide without limit and
whose progeny (or offspring) include both stem cells and cells
destined to differentiate into specialized cell types (Figure 1; for
an animated version of this Figure see http://www.BiochemJ.org/
bj/404/0169/bj4040169add.htm). Many stem cells have the
potential to generate more than one type of differentiated progeny
(i.e. they are multipotent). Stem cells therefore hold great clinical
promiseintermsoftheirabilitytoprovidereplacementsfortissues
damaged by the processes of aging, injury and disease.
Stem cells are characterized by the fact they are undiffer-
entiated. This presents a major obstacle to their identiﬁcation,
particularly for the more primitive stem cells which are normally
in a quiescent state and do not express many antigens. It is,
presumably, the overall combination of positive and negative
antigen markers that are important in the identiﬁcation of stem
cells. Even though stem cells are undifferentiated, during devel-
opment they are already committed to becoming one particular
cell or tissue type. Therefore, an epidermal (skin) stem cell can
only form keratinocytes, and an intestinal stem cell can only
form intestinal cell types present in the villus. This demonstrates
the phenomenon of ‘developmental hierarchy’, which means that
cells of the early blastocyst can form any cell and then become
restricted toadifferentiatedcelltype.Forexample,theprecursors
of the intestinal stem cells are committed in the germ layer, which
is known as the endoderm, and stem cells in the haematopoietic
lineage are committed in the mesoderm. It is believed that once
a cell is committed, it cannot cross the germ-layer boundary to
form another cell type (for example, a mesodermally derived cell
cannot form an endodermal cell; see below).
Stem cells are found in both the developing embryo [ES
(embryonic stem) cells], as well as in adult tissues. ES cells
are pluripotent, with the capacity to generate cells from all
three germ layers (endoderm, mesoderm and ectoderm) [1]. The
announcement that human stem cells could be derived from the
inner cell mass of the blastocyst was met with much excitement,
but the ethical issues surrounding the use of human ES cells in
regenerative medicine [2] will not be dealt with in the present
review.
Adult stem cells (sometimes referred to as tissue-speciﬁc or
somatic stem cells) are undifferentiated cells found amongst
differentiated cells that are present in certain organs of the body.
The primary role of adult stem cells is to maintain and repair the
tissue in which they are found. In adult tissues, stem cells exist
in the gastrointestinal tract, bone marrow, the central nervous
system, skin, muscle, cornea and retina (reviewed in [3]). Two
tissues that exhibit a high cell-turnover rate, the intestine and
skin, have relatively well-characterized stem cell compartments.
However, in tissues such as the liver, where the true liver cells (or
hepatocytes) have a low turnover rate [4], a stem cell capable of
self-renewing and producing liver progeny has, to date, remained
elusive [5]. In the present review, we will use the intestine as an
example of a stem cell compartment, then examine the evidence
forstemcellprogenitorsintheliverandpancreas,andalsodiscuss
brieﬂy the process of transdifferentiation as a means of producing
differentiated cells for therapeutic transplantation.
INTESTINAL STEM CELLS
The intestine is a constitutively developing tissue, undergoing
constantrenewalanddifferentiationfromastemcellcompartment
throughout the entire life of an organism. Interestingly, many
of the molecular mechanisms underlying the maintenance and
differentiationofadultintestinalstemcellsarethesamepathways
regulating intestinal organogenesis. Therefore, understanding
intestinaldevelopmentwillhelpidentifythekeyextracellular(for
example, morphogens and growth factors) and intracellular
(signalling intermediates and transcription factors) components
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Figure 1 Scheme of stem cell self-renewal and differentiation
Stem cells are capable of maintaining the stem cell compartment through self-renewal and can
also give rise to progenitor cells that may undergo subsequent differentiation along more than
one lineage to generate cell-type-speciﬁc derivatives. For an animated version of this Figure,
see http://www.BiochemJ.org/bj/404/0169/bj4040169add.htm.
responsible for directing stem cells towards an intestinal
phenotype.
The primitive gut tube is composed of three germ layers: the
endoderm, which forms the epithelial lining of the intestine;
the mesoderm, which forms the smooth muscle layers; and the
ectoderm, from which the neural crest cells that will form
the enteric nervous system are derived. The developing gut is
subject to differentiation in several planes, the AP (anterior–
posterior), DV (dorsal–ventral), LR (left–right) and the RAD
(radial)axis,thusallowingtheformationofvariedandspecialized
structures along the entire length of the gut tube. Initial intestinal
endoderm speciﬁcation is regulated, in part, by epithelial–
mesenchymal interactions along the AP axis. The speciﬁcation
is probably mediated by differential mesodermal expression
of the Hox (homeobox)-containing transcription factors [6–8].
Cytodifferentiation of the intestinal epithelium in the developing
rat begins at approx. E14 (embryonic day 14) when the endoderm
undergoes a transformation from a pseudostratiﬁed epithelium
to a columnar monolayer, a process resulting in the formation
of numerous villi along the cranio–caudal axis (head-to-tail or
AP axis) [9]. Intestinal villi are characteristically long and thin,
and interspersed by areas of proliferating epithelium that will
become the intervillus crypts (crypts of Lieberk¨ uhn). The crypt–
villus structures are maintained into adulthood and form the
basic functional units of the intestine. The crypt–villus axis is
established in response to two signalling molecules: IHH (Indian
hedgehog) and BMP (bone morphogenetic protein). IHH is
expressed during development in the colonic epithelium and
proliferating epithelial precursors of the small intestine. A
dramatic reduction in villi size and the number of proliferating
cells is observed in the intestine of Ihh
−/− mice [10], supporting
a role for IHH in promoting cell renewal. A possible role for
IHH in controlling cell fate speciﬁcation is also implicated by the
observation that the colonic epithelium in Ihh
−/− mice remains
a multilayered epithelium of undifferentiated cells, rather than
becoming a monolayer of cells organized into crypts and surface
epithelium [11]. Maintenance of intestinal stem cell self-renewal
is also mediated through the antagonistic effects of BMP on
the Wnt signalling pathway [12] (see below). Suppression of
BMP signalling leads to ectopic crypt formation in the villus
and abnormal growth of the intestinal epithelium [13]. Cases of
juvenile polyposis syndrome (an autosomal dominant disorder
characterized by the development of polyps throughout the
gastrointestinal tract in the ﬁrst decade or two of life) have been
shown to be due to mutations in SMAD4 and BMP receptor 1A,
both components of the BMP signalling pathway [13].
Intestinal stem cells located in the base of the crypts of
Lieberk¨ uhn give rise to progenitors that will differentiate into
absorptiveenterocytesorsecretorycells,suchasenteroendocrine,
goblet and Paneth cells [14]. In 1981 Bjerknes and Cheng [15]
put forward the stem cell zone model that proposed the stem cell
state is supported by the microenvironment (or niche) around
cell positions 1–4. However, cells moving up to position 5 are
induced to begin a programme of differentiation into one of the
intestinalcelllineages.Eachcryptisestimatedtocontainbetween
one and six slowly dividing stem cells that give rise to a transient
population of rapidly dividing progenitor cells, the majority of
which migrate out of the crypt into the villi where they will
differentiateandeventuallybeshedandreplacedbynewcells.The
Paneth cells, in contrast, differentiate and migrate back into
the stem cell zone at the base of the crypt [15,16]. A model to
explain the ability of intestinal stem cells to maintain and protect
theirgeneticintegritywasﬁrstdescribedbyCairnsandcolleagues
over 25 years ago [17]. In this study [17], it was proposed
that stem cells could selectively donate newly synthesized DNA
strands to their descendants while retaining old DNA strands
(Figure 2). Although controversial at ﬁrst, the Cairns model
has now been conﬁrmed by the demonstration of asymmetric
chromatid segregation using a technique to label template strands
of DNA during development with tritiated thymidine and newly
synthesized strands with bromodeoxyuridine [18].
Maintenance of the gut stem cell compartment is dependent,
in part, on signalling through the Wnt–β-catenin–Tcf-4 (T-cell
factor 4) pathway [19,20]. Wnt genes encode secreted proteins
thatactviamembrane-boundWntreceptors,whichinturn,leadto
the nuclear translocation of β-catenin and Tcf complexes where
they mediate the transcriptional activation of numerous genes.
Expression of Wnt genes during mouse development suggested
a role for Wnt signalling in determining AP boundaries in the
gut [21]. Whereas β-catenin is localized to the membrane of all
cells in the villi and crypts in adult intestine, nuclear β-catenin
is localized only in the epithelial cells within the crypt. The Wnt
effector Tcf-4 is also expressed at high levels in the cells of the
crypt, and Tcf-4-null mice exhibit loss of the intestinal stem cell
compartment and die at birth, prior to crypt formation [22,23].
Furthermore, expression of the Wnt repressor Dickopf, under the
control of the villin promoter in the intestine of transgenic mice,
leads to a dramatic reduction in proliferative activity, the absence
of crypts and perturbation of villi formation [24].
Cellular differentiation in the intestine is also regulated by the
Notch–Delta–Hes1signallingpathway(reviewedin[25]).Math1,
a downstream target of Hes1, has been localized to the progenitor
cell compartment of the developing and adult crypt. Math1
homozygous mutant mice show a complete loss of goblet, Paneth
and enteroendocrine cells, indicating a requirement for Math1
in lineage speciﬁcation. Interestingly, enterocytes arise from
the Math1-negative progenitors, suggesting that two progenitor
cell types normally reside in the crypt [26]. Math1-positive cells
are directed towards an endocrine phenotype through the
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Figure 2 Representation of the cellular components of the intestinal crypt and the signalling pathways involved in differentiation and maintenance of the
crypt–villus axis
The intestinal crypt–villus axis can be divided into three zones: the lower stem cell and Paneth cell compartment, the cell ampliﬁcation zone, both located in the crypt; and the cell differentiation zone
that constitutes the villus epithelium. Stem cells located at approx. position 5 maintain genomic integrity through chromatid segregation by donating newly synthesized DNA to their offspring while
retaining their originalgenomiccontent. Progenitorsarising in the stem cell compartmentmay differentiate into Paneth cells that migrateinto thebottom ofthe crypt,directed byinteractionsbetween
EphB2/3 and ephrin, where they will reside for up to 20days before being replaced by new Paneth cells. Alternatively, stem cell progenitors enter the ampliﬁcation zone in the crypt. When the stem
cell progenitorsreach the base of the villus they will undergocell-cycle arrest and differentiate along an absorptiveenterocyte, goblet or enteroendocrinecell lineage. Cells shed at the tip of the villus
are replaced by constant generation of new progenitors in the crypt. Wnt and Notch signalling components are restricted to the base of the crypt where they play an important role in maintaining the
stem cell compartment. BMP and hedgehog signalling along the crypt–villus axis have been shown to regulate cell renewal and lineage speciﬁcation.
activity of Ngn3 (neurogenin 3), whereas the expression of the
transcriptional repressor Gﬁ1 (growth factor independence 1)
directs the cells toward a secretory cell lineage (Paneth/goblet
cells). Differentiation of intestinal progenitors is also dependent
on their ability to migrate out of the crypt, a process regulated by
the expression of ephrin receptors and their ligands. Differentiat-
ingcells,migratingawayfromthecrypt,expresstheligandephrin
B1, whereas the receptors EphB2 and EphB3 are expressed in the
progenitor cell compartment [27]. Paneth cells normally reside
in the base of the crypt, a region to which the EphB3 receptor is
restricted in the adult intestine. In EphB3
−/− mice, Paneth cells
are seen scattered throughout the base of the villus and the crypt,
further supporting a role for ephrin signalling in maintaining the
correct cellular patterning of the intestinal crypt [27].
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Although the high rate of self-renewal required for general
maintenance of the intestine has facilitated the location of stem
cell and progenitor cell compartments, rapid cell turnover may
contributetointestinalstemcellsusceptibilitytogeneticalteration
under conditions of inﬂammation or infection, the consequence
of which is the development of metaplastic lesions. For example,
the Drosophila Hox transcription factor Cdx1 (caudal-related 1),
a direct target of Tcf-4, is expressed in the developing intestinal
endoderm and the proliferating cells of the adult crypt [28,29].
Cdx1 and another member of the caudal-type Hox gene
family, Cdx2, have been localized to intestinal metaplastic tissue
of the human stomach, suggesting that ectopic expression of
this gene may contribute to the mechanism underlying intestinal
metaplasia [30]. Animal models in which Cdx2 is misexpressed
in the gastric mucosa also develop intestinal metaplasia that
are characterized by the presence of intestinal cell types [31].
Together, these data indicate the importance of strict regional
expression of Cdx1 for the maintenance of the intestinal stem cell
compartment and normal boundaries within the gut.
Despite the apparent wealth of information regarding the
maintenanceanddifferentiationofintestinalprogenitorcells,lack
of a stem-cell-speciﬁc marker continues to hamper progress. A
study [32] suggests that Mushasi-1, a marker for neural stem cells
expressed in the lower crypt, may be a marker for intestinal stem
and early progenitor cells.
LIVER STEM CELLS
The embryonic liver arises as an outgrowth of the ventral
foregut endoderm. Hepatic speciﬁcation occurs at E8.0, when
the foregut endoderm is brought into close proximity with the
cardiac mesenchyme, a process dependent on both BMP and
FGF (ﬁbroblast growth factor) signalling. In the absence of FGF
and BMP signals in the mouse, the anteroventral endoderm
assumes a pancreatic fate [33]. The transcription factors Foxa1
(forkhead box A1) and Foxa2 are also required for initiation
of liver development [34]. Following speciﬁcation, the hepatic
endoderm proliferates to form the liver bud (E9.5), and by E10.5
thefundamentalsinusoidalstructureoftheliverbecomesapparent
as the early hepatoblasts migrate into the mesenchyme of the
surrounding septum transversum. In addition to interactions with
the developing vascular system [35] and the effects of factors
such as HGF (hepatocyte growth factor) [36], liver outgrowth is
regulated by the transcription factors Prox1 and Hex. The lack of
hepatocytesobservedinHex
−/− miceindicateanessentialrolefor
Hex in differentiation of the hepatic endoderm [37], whereas in
Prox1
−/− animalsthedifferentiatinghepatocytesareencapsulated
by the presence of a basement membrane abnormally rich in
collagenIVandlaminin,suggestingaroleforProx1inhepatocyte
migration [38].
A role for Wnt signalling during liver development has also
been implicated [39]. A recent report by Ober and co-workers
[39]hasdemonstratedtherequirementforamesodermallyderived
Wnt signal to direct liver speciﬁcation in the zebraﬁsh embryo.
The Prt (Prometheus) gene, identiﬁed as a novel homologue of
Wnt2b (and closely resembles the mouse orthologue Wnt13),
is expressed in the lateral plate mesoderm in the time frame
during which liver speciﬁcation occurs (reviewed in [40]). Prt
mutants exhibit an absent or severely reduced liver due to defects
in hepatic fate speciﬁcation. In addition, a role for Wnt signal-
ling in promoting the speciﬁcation and survival of the biliary cell
lineageinmousehasbeensuggested[41].Intheabsenceofserum,
cultured embryonic liver exhibits extensive loss of parenchymal
and biliary architecture, reduction in proliferation and increased
apoptosis.WhensupplementedwithWnt3a-conditionedmedium,
however, duct-like structures comprising proliferating cells,
positive for the biliary marker CK19 (cytokeratin 19), were
observed in the embryonic livers. These data suggest that Wnt
signalling may play a role not only in the early phase of liver
speciﬁcation, but also in the determination of speciﬁc hepatic cell
lineages.
The epithelial cells of the foetal liver, the hepatoblasts,
are bipotential progenitor cells. Both the hepatocytes (i.e. the
liver parenchymal cells) and biliary epithelial cells are derived
from the hepatoblast [42]. Sandhu et al. [43] demonstrated the
ability of E14 rat hepatoblasts to replicate and differentiate
when transplanted into the liver of DPPIV (dipeptidyl peptidase
IV)-deﬁcient rats (DPPIV is an exopeptidase located at
the apical membrane of hepatocytes). The transplanted cells
generatedclustersofDPPIV
+ hepatocytesandcomprised5–10%
of the liver population 6 months post-transplantation. The
hepatoblasts also generated bile duct structures that became
integrated into the host biliary system. Similar replicative and
differentiation capacities have been shown in isolated human
foetal hepatoblasts transplanted into mice with SCID (severe
combined immunodeﬁciency) [44]. As an alternative to using
primary hepatoblasts, some research groups have now generated
embryonic progenitor cell precursor lines from mouse and
rat, although such a cell line has not yet been described in
human liver [45,46]. The BMEL (bipotential mouse embryonic
liver) cell line described by Strick-Marchand and Weiss [45]
has been shown to differentiate into both bile duct cells and
hepatocytes during liver regeneration in Alb-uPA (albumin-
urokinase plasminogen activator)/SCID transgenic mice. These
data reinforce the importance of such cells for the development
of cell-based therapies for liver disease, as they provide a pool of
cells that can be readily expanded, genetically manipulated and
potentially used in transplantation.
The fate and differentiation of wild-type foetal liver cells was
determined recently by Oertel et al. [47], following transplan-
tation into DPPIV
− rats. Foetal liver cells showed continuous
proliferation potential for 6 months following transplantation,
and subsequent differentiation into hepatocytes re-populating
23.5% of the total liver mass. Interestingly, the transplanted cells
exhibited reduced apoptosis and a greater proliferative activity
than host hepatocytes. Increased apoptosis of host hepatocytes
adjacent to the transplanted cells led Oertel and colleagues [47]
to propose that a process termed cell–cell competition (described
previously in Drosophila [48]) may operate to replace functional
hepatic tissue in the transplanted animals.
Considerable controversy continues to surround the existence
of an adult liver stem cell. Under conditions of severe parenchy-
mal loss, the hepatocytes themselves may be considered as func-
tional stem cells due to their remarkable ability to self-replicate
to restore liver mass during regeneration [49,50]. Furthermore,
animal models of liver disease have demonstrated that trans-
planted hepatocytes undergo substantial clonal expansion and
are sufﬁcient to rescue mutant phenotypes. For example, the
FAH (fumarylacetoacetate hydrolase)-deﬁcient mouse strain is
a model for tyrosinaemia type 1. This mutant mouse can
normally survive only by liver transplantation or treatment with
the drug NTBC [2-(2-nitro-4-triﬂuro-methylbenozyl)-1,3-cyclo-
hexanedione]. NTBC treatment prevents tyrosinaemia-induced
liver failure by inhibiting the enzyme 4-hydroxyphenylpyruvate
dioxygenase, which functions upstream of FAH. However, in
FAH-deﬁcient mice, transplanted wild-type mature hepatocytes
readily proliferate within the diseased liver and alleviate
symptoms [51]. What is more interesting is the remarkable re-
population potential of hepatocytes. Using the FAH-knockout
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mouse model, Grompe and co-workers [51] demonstrated that
normal adult hepatocytes serially transplanted are capable of at
least 80 doublings.
Liver regeneration is also mediated through the activation of
a potential stem cell compartment localized to the periductular
junction or canals of Hering [52,53]. In response to injury by
carcinogenicagents,smallcellscontainingovalnucleiandlimited
cytoplasm (termed oval cells in rodents or hepatic progenitor
cells in humans) proliferate within the smallest branches of the
intrahepatic biliary tract [49,54]. The oval cell is considered to
be the progeny of the elusive hepatic stem cell and is bipotential
in nature, capable of giving rise to both hepatocytes and bile
duct cells. It was speculated at one stage that oval cells were
derived from bone-marrow precursor cells. This was based on the
observation that oval cells express many of the markers typically
associated with haematopoietic cells, for example, CD34, Thy-1,
c-Kit and Flt-3 (Fms-related tyrosine kinase 1) [55]. However, a
study carried out by Dabeva et al. [56] now forms the basis of
the widely accepted idea that oval cells do arise from the stem
cell niche within the canals of Hering. In order to determine
the origin of oval cells, Dabeva et al. [56] transplanted 5×10
7
wild-typemalebone-marrowcellsintolethallyirradiatedDPPIV
−
female rats, and subsequently subjected the rats to three different
protocols to promote activation and expansion of the oval cell
compartment. Although in each model a marked accumulation
and increase in CK19-expressing oval cells were observed, less
than 1% of the oval cells showed dual CK19/DPPIV
+ labelling,
indicatingthattheyprobablydonotarisefrombone-marrowstem
cells. Interestingly, oval cells have been identiﬁed in the ductal
system of the pancreas in copper-depleted rats [57]. The copper-
depleted rat is signiﬁcant, because the copper-deﬁciency regime
followedbyre-feedingwithanormalcopper-containingdietleads
totheappearanceofhepatocyte-likecellsinthepancreasoftreated
animals.Theectopichepatocyteswerethoughttobederivedfrom
pancreatic oval cells. When oval cells from copper-depleted rats
were transplanted into rats they did, indeed, begin to express
hepatic markers, such as albumin [56].
Although the in vivo models for the transdifferentiation of
pancreatic cells into hepatocytes have been extremely useful
and demonstrate the potential for pancreas-to-liver transdiffer-
entiation [58], it is more difﬁcult to determine the molecular
or cellular mechanisms from these studies. The generation of
an in vitro model for transdifferentiation (discussed below) has
providedsomeofthemoleculardetailsfortheswitchinphenotype
from a pancreatic to a hepatic cell type.
PANCREATIC STEM CELLS
The pancreas comprises two distinct cell types that are referred
to as exocrine and endocrine cells. The exocrine region of the
pancreas produces and secretes digestive enzymes (for example,
amylase) in response to hormones from the gastrointestinal
tract. The endocrine cells of the pancreas are arranged in
compact spheroidal clusters called the islets of Langerhans
which are dispersed throughout the acinar matrix. There are
ﬁve endocrine cell types and each secretes a distinct pancreatic
hormone. The cell types are: α-cells (glucagon), β-cells (insulin),
δ-cells (somatostatin), F- or PP-cells (pancreatic polypeptide)
and ε-cells (ghrelin). In Type 1 diabetes, the insulin-producing
β-cells of the endocrine pancreas are inappropriately destroyed
by autoimmune attack, resulting in diabetes. An ideal therapy
for diabetes would achieve normoglycaemia through β-cell
replacement. Pancreatic stem cells have been proposed as a
potentially feasible source of novel β-cells for transplantation.
However, there has been considerable controversy as to the
existence and exact nature of any stem cells in the adult pancreas.
As shown by early studies, the pancreas has a very limited
regenerative capacity. The exocrine tissue in hamsters can be
selectively damaged by the replacement of methionine in the
diet with ethionine, and regeneration of the damaged tissue
can be provoked by the restoration of methionine [59]. Local
inﬂammation and ﬁbrosis caused by the cellophane wrapping of
the pancreas in hamsters can also induce islet neogenesis from
hyperplastic ducts [60]. Such results have led to the proposal of
potential candidates for adult pancreatic stem cells. They include
pancreaticductalcells,exocrinecells,Ngn3-positivecells,nestin-
positive cells and oval cells, all of which are discussed below.
Some of these cells have the potential for lineage-restricted
differentiation into pancreatic phenotypes.
During normal embryogenesis, the pancreas, similar to the
liver and the intestine, is derived from the deﬁnitive endoderm
[61]. However, commitment to a pancreatic fate is set up by an
activin-βB- and FGF2-mediated repression of sonic hedgehog
expression in pre-pancreatic dorsal endoderm [62,63]. This
induces the expression of the master regulator of pancreatic
development, Pdx1 (pancreatic and duodenal homeobox 1), and
marks the precursor cell population for pancreatic development.
A hierarchical cascade of pancreatic developmental transcription
factor expression in these progenitor cells then gives rise to
the endocrine and exocrine cell populations and the distinct
cell types within each of the populations [64,65]. For example,
transcription factors such as Ngn3 and NeuroD1 are essential
for early endocrine lineage determination, whereas Hes1, p48
and Mist1 are expressed in the cells which contribute to the
exocrine lineage [65–67]. Furthermore, sequential expression
of Nkx2.2, Pax4, Nkx6.1, MafA, Pax6 and Pdx1 determine
insulin-producing β-cell fate, whereas Brn4, Arx1, Nkx6.2 and
MafB expression promote the glucagon-producing α-cell fate
[65,66,68].Theunderstandingofthetranscriptionfactorhierarchy
and the various growth factors involved in pancreatic develop-
ment and maturation has proved useful in reprogramming other
cell types into pancreatic cells. Recently, a ﬁve-stage protocol
that mimics pancreatic development, taking human ES cells
throughdifferentidentiﬁableendodermalintermediates,hasmade
it possible to eventually produce endocrine-hormone-expressing
cells in vitro, simply by the application of different combinations
of growth factors, such as activins, Wnts, BMPs and FGFs when
ES cells are in culture [69].
In vivo, endocrine cells may arise by sequential differentiation
of ductal epithelial stem cells [70,71]. Islet-like structures then
bud off and migrate into the acinar tissue. Immunohistochemical
localization of single β-cells near and within ductal tissue,
following pancreatic injury, was originally presented as evidence
that new β-cells in the adult could similarly originate from stem
cells within the ductal tissue [72]. Furthermore, it is possible
to generate islets containing α-, β-a n dδ-cells from pluripotent
stem cells isolated from adult pancreatic ductal epithelial cells
in long-term culture [73]. However, rapid proliferation of ductal
cells could make them lose their ductal phenotype and revert to
multipotent cells that then differentiate into other cell types [74].
Ductal cells can also transdifferentiate into other cell types,
including squamous, mucinous and pyloric cells, and undergo
malignant transformations into pancreatic adenocarcinomas [75].
Given these two lines of evidence, some controversy exists as to
whether the cells within the ducts that give rise to β-cells are
true ductal stem cells or differentiated ductal cells with some
transdifferentiation capacity.
The exocrine and endocrine pancreas arises from a common
Pdx-1-expressing domain of the foregut endoderm [61,76]. This
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observation revoked the idea that the adult pancreatic stem cells,
which can generate both endocrine and exocrine cell types, might
reside among the exocrine cell population [77]. The non-endo-
crine pancreatic epithelial cells that remain after islet isolation
whenco-transplantedwithfoetalpancreaticcellsunderthekidney
capsule of immunodeﬁcient mice are capable of differentiating
into endocrine cells [77]. However, lineage-tracing studies
have demonstrated that acinar–islet transitions, which occur
both in vivo and in vitro, could primarily be due to transdif-
ferentiation and not as a result of the existence of endocrine
stem or progenitor cells within the pancreatic exocrine tissue
[78,79].
Nestin-positive cells within the pancreatic islets and ductswere
also postulated to be putative multipotent stem cells that provide
precursors for neogenesis of endocrine cells [80,81]. Nestin is
an intermediate ﬁlament protein that is a marker of neural stem
cells [82]. The nestin-positive cells within the islets and ducts are
negative for endocrine hormones and ductal markers respectively,
but, when isolated and expanded in vitro, they can differentiate
intoinsulin-andglucagon-producingcells[80,81].However,later
studies characterized the nestin-positive cells of the pancreas
as being either reactive stellate cells or angiogenic endothelial
cells [83]. Immunohistochemical analyses of nestin-positive cells
in vivo showed that the cells were mesenchymal in nature, and
nestinwasnotco-expressedwiththeepithelialmarkerE-cadherin
at any stage during development of the mouse pancreas [82].
Furthermore, although nestin demarcates a cell population that
differentiates along neuronal and muscle lineages, these cells do
not contribute to insulin-producing cells during normal human
development [84].
Some of the most convincing evidence points to Ngn3-positive
cells as pancreatic progenitors, both during embryogenesis and in
the adult mouse. Using an inducible Cre-ER
TM-LoxP system to
follow the progeny of Ngn3-a n dPdx1-expressing cells, Ngn3-
positive cells speciﬁcally give rise to endocrine cells, whereas
Pdx1-positive cells contribute to exocrine, endocrine and ductal
tissue of the pancreas [85]. Although these Ngn3-positive cells
behave as endocrine progenitors, their self-renewal capabilities
and the possibility that a subpopulation of these cells might be
true pluripotent stem cells remain unresolved.
The anatomical proximity of the developing liver and
pancreas has also led to the suggestion of the existence of a
commonhepatopancreaticstemcell[86].Theseendodermalcells,
exhibiting bipotentiality, follow a default pancreatic programme
to start initially expressing Pdx1, and subsequently markers
speciﬁc to endocrine (Ngn3, Isl1 and NeuroD) or exocrine (p48)
lineages.ItisonlytheFGFsignallingprogrammefromthecardiac
mesoderm that diverts the bipotential cells to commit to a hepatic
lineage [86].
Anintrinsicpancreas-derivedmultipotentprecursorpopulation
from the adult pancreas which is capable of differentiating
in vitro into pancreatic α-, β-a n dδ-cells, pancreatic exocrine
cells and stellate cells, neurons and glial cells has also been
reported [87]. However, controversy still remains as to whether
these precursor or stem cells are predominantly responsible for
the adult pancreatic regeneration observed in vivo. In the case
of β-cells, in vivo genetic lineage tracing showed that normal
β-cell replenishment and generation of novel β-cells following
pancreatectomy occur by the replication of pre-existing β-cells,
rather than via the postulated pluripotent stem cell population
[88]. This study [88] questions the signiﬁcance of the in vivo
roles of any pancreatic stem cell, but it does not rule out the
possibility of their existence. Although the use of adult pancreatic
stemcellswouldprovetobehighlyrevolutionaryindevelopingan
innovative diabetes therapy, to date, a fully deﬁned and clinically
applicable true pluripotent pancreatic stem cell still awaits to be
identiﬁed, isolated and characterized.
METAPLASIA AND TRANSDIFFERENTIATION AS A MEANS
OF GENERATING DIFFERENTIATED CELL TYPES
Metaplasia is deﬁned as the conversion, in postnatal life, of
one cell type into another, and can include conversion between
stem cells of different tissues. Transdifferentiation belongs to a
subset of metaplasia and involves conversion of one terminally
differentiated cell type into another [89]. Both metaplasia and
transdifferentiation are largely associated with tissue damage.
There is now some evidence to suggest that, through a process
of cell fusion, tissue-speciﬁc stem cells can give rise to cells
characteristic of a completely different tissue. One of the best-
documented examples of this type of cell conversion is seen
in adult bone-marrow-derived stem cells. Bone marrow contains
mesenchymal stem cells and HSCs (haematopoietic stem cells),
which can generate neuronal cells, pneumocytes, skeletal and
cardiac muscle, as well as hepatocytes (reviewed in [90]).
The derivation of hepatocytes from circulating HSCs was ﬁrst
documented in the rat following a complex protocol designed to
prevent normal liver regeneration and cause oval cell activation.
Lethallyirradiatedfemaleratsweresubjectedtotreatmentwith2-
acetylaminoﬂuoreneandcarbontetrachloridetoblockhepatocyte
regeneration and cause hepatocyte necrosis respectively. The
fate of transplanted Y-chromosome-positive oval cells was then
monitored in the recipient females [91]. Hepatic engraftment
of bone-marrow-derived cells was observed by the appearance of
Y-chromosome-positive hepatocytes approx. 13 days after liver
injury. In subsequent studies, examination of the liver of female
recipients of male bone marrow revealed that hepatocytes may
be derived from HSCs in humans as well [92,93]. Lagasse
and colleagues [94] also reported that HSCs differentiated into
hepatocytes to alleviate the symptoms in FAH knockout mice;
however,closerexaminationofthedatarevealedthatregeneration
in their model arises through cell fusion, rather than by a true
metaplastic change [95]. The reverse conversion from a hepatic
progenitor cell line into cells of a pancreatic lineage has also
been demonstrated in an in vitro model. WB cells represent a
liver progenitor cell line and can be reprogrammed into insulin-
producing cells by the lentivirus-mediated transduction of the
pancreatic transcription factor Pdx1 [96]. Pdx1 was modiﬁed to
include the Vp16 activation domain from herpes simplex virus.
The β-cells produced from WB cells were transplanted into a
mouse model of diabetes and hyperglycaemia was reversed.
In addition to stem-cell-derived hepatocytes and pancreatic
cells, several laboratories have now demonstrated the generation
of these cell types by transdifferentiation. Transdifferentiation of
pancreatic cells into hepatocytes has been observed in a number
of model systems which include: the copper-depleted rat
described by Rao et al. [57,97], following transplantation of
a cell population enriched for pancreatic epithelial progenitors
into the rat liver [56], and in transgenic mice overexpressing
keratinocyte growth factor in the pancreas [98] (Figure 3).
Hepatic transdifferentiation has also been described as a naturally
occurring phenomenon in the vervet monkey (Cercopithecus
aethiops) and in human pancreatic tumours [99,100].
Studies carried out in our laboratory have described the
conversion of the rat pancreatic tumour cell line AR42J-B13 into
hepatocyte-like cells. The transdifferentiated hepatocytes possess
many of the functional characteristics of normal hepatocytes
[101–104]. These observations have been conﬁrmed by two in-
dependent groups [105,106]. Bouwens and colleagues [107] have
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Figure 3 Diagram showing the generation of hepatocytes from embryonic and adult cells through normal development, regeneration and transdifferentiation
During normal liver development, hepatocytes and biliary epithelial cells are generated by differentiation of embryonic hepatoblasts. Under conditions of regeneration, both hepatocyte and bile duct
lineagesarisefromovalcells,theprogenyoftheputativehepaticstemcell.Hepatocytescanalsobegeneratedfrompancreaticcelltypes:eitherthroughthetreatmentofratswithacopper-deﬁcientdiet
in vivo or through the treatment of the pancreatic cell line AR42J-B13 with 1 µM dexamethasone in vitro.
also shown that addition of dexamethasone can provoke a hepatic
phenotype in cultured adult rat exocrine cells. Furthermore, the
molecular basis of the switch from pancreatic to hepatic pheno-
typeinvitroismediated,atleastinpart,bythetranscriptionfactor
C/EBPβ (CCAAT/enhancer-bindingproteinβ)[101].Embryonic
expression of C/EBPβ (and C/EBPα) is conﬁned to the region
of the developing liver, supporting the idea that C/EBPs are
important in liver development [108].
The conversion from liver cells into pancreatic cells has also
been achieved [109–114]. The ability to interconvert between
liver and pancreas reﬂects the close developmental relationship
betweenthesetwotissuesandsupportsthetheorythattransdiffer-
entiation is driven by one or two so-called ‘masterswitch’ genes
thatdistinguishthetwotissuesduringdevelopment[115].Identiﬁ-
cation of such masterswitch genes will be useful in the future
for directing stem cell differentiation towards liver, pancreatic,
intestinal or other phenotypes.
SUMMARY AND CONCLUSIONS
In recent years, there has been a considerable amount of interest
in using stem cells to repair or regenerate damaged tissues. Stem
cells can be used as a source for cell transplantation due to their
ability to differentiate into a variety of cell types. This strategy
is one branch of ‘regenerative medicine’ which refers to the
stimulation of regeneration of damaged organs and constitutes
one of the fundamental challenges to tissue engineers and
biologists.
Several problems still remain to be resolved before pancreatic
and hepatic stem cells can be therapeutically useful. The ﬁrst
is to determine whether the studies performed on animal cells
can be applied to human cells. At present, it is not clear if the
markers identiﬁed on rodent liver and pancreas progenitor stem
cells are also expressed in the equivalent human cells. Therefore
the ﬁrst hurdle will involve the identiﬁcation of suitable stem
cell markers. One approach to this problem might be through
large-scalegenomicorproteomicscreeningofputativestemcells.
Oncereliablemarkershavebeenfoundthisshouldmakeisolation
and expansion easier. The second problem to be resolved will be
to elucidate the rules for differentiation of stem cells towards
functional cell types. Identiﬁcation of the extracellular cues in
stem cell differentiation and the key regulatory transcription
factors will require the development of new in vitro culture
models. Identifying the individual steps in the differentiation
of stem cells to functional cells is important for two distinct
reasons. First, the bioassay provided by stem cell differentiation
might enable a shortcut to the molecular understanding of the
developmentofindividualtissues,sincethestepsinvolvedinstem
cell differentiation are probably similar to what happens during
embryonicdevelopment(thesamelogiccanalsobeappliedtothe
stepsintransdifferentiation).Theinformationobtainedfromstem
cell studies may also be complementary to that obtained from
the direct investigation of embryonic development by knockout
studies and transgenic approaches. Secondly, understanding the
molecular basis of stem cell differentiation may have a practical
value in the design of novel therapies for treating degenerative
diseases. For example, differentiation of pancreatic stem cells to
glucose-responsive insulin-expressing β-cells is an important
therapeutic goal in diabetes research. Ultimately, identifying
tissue-speciﬁc adult stem cells and the mechanisms involved in
their differentiation to speciﬁc cell lineages will pave the way to
developing novel therapeutic strategies for treating liver failure
and diabetes.
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